Circular RNA MYLK as a prognostic biomarker in patients with cancers: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Circular RNA MYLK as a prognostic biomarker in patients with cancers: A systematic review and meta‐analysis

Published:2022-06-14 Issue:9 Volume:5 Page:
ISSN:2573-8348
Container-title:Cancer Reports
language:en
Short-container-title:Cancer Reports

Author:

Foroumadi Roham¹²³^ORCID,Rashedi Sina¹²³^ORCID,Asgarian Sara⁴,Mardani Mahta¹²,Keykhaei Mohammad⁴,Farrokhpour Hossein¹²³,Javanshir Salar⁵,Sarallah Rojin⁵,Rezaei Nima²⁶⁷

Affiliation:

1. School of Medicine Tehran University of Medical Sciences Tehran Iran

2. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA) Universal Scientific Education and Research Network (USERN) Tehran Iran

3. Non‐Communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences Tehran Iran

4. School of Medicine Iran University of Medical Sciences Tehran Iran

5. School of Medicine Tehran Medical Sciences Branch, Islamic Azad University Tehran Iran

6. Research Center for Immunodeficiencies Children's Medical Center, Tehran University of Medical Sciences Tehran Iran

7. Department of Immunology School of Medicine, Tehran University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1653

Reference38 articles.

1. The global cancer burden: necessity is the mother of prevention

2. Cancer Statistics, 2021

3. Translation of CircRNAs

4. Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types

5. The progress of circular RNAs in various tumors;Wang D;Am J Transl Res,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FLASH Radiotherapy Versus Conventional Cancer Therapy: Promises, Paradoxes and Problems;International Journal of Translational Medicine;2024-09-11

2. Circular RNA in autoimmune diseases: special emphasis on regulation mechanism in RA and SLE;Journal of Pharmacy and Pharmacology;2022-12-30